MSB 5.24% $1.11 mesoblast limited

Cell Therapy News/Articles, page-4583

  1. 3,875 Posts.
    lightbulb Created with Sketch. 1315
    It's not just about surviving the first wave. Let's hope MSB can do that and yes it is obviously the first consideration. What about recovery

    https://www.eatthis.com/fauci-post-covid-syndrome/

    Heart, kidney, nerve and neurologic disorders unfortunately not in small numbers either. Hope that these people don't get reinfected in the advent of a second wave.

    Now would anyone know of a single company that has done a massive amount of work on the above? MSB

    Remestemcell L has been described as a therapy of last resort. Why? Other drugs appear to be cheap however do they address the long term medical conditions of those that do survive. Our P2/3 trial could provide the answers.

    Should the P2/3 trial be stopped before this is definitely answered even though the results may be outstanding? NO

    It would be a massive mistake to presume that our treatment would only be used as a last resort leaving those that do survive a life of ill health and huge economic cost to the community. It may be far more benefit to use our therapy first and only use the others as a last resort.

    Good luck and stay safe.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.11
Change
0.055(5.24%)
Mkt cap ! $1.261B
Open High Low Value Volume
$1.05 $1.13 $1.04 $6.781M 6.207M

Buyers (Bids)

No. Vol. Price($)
3 43856 $1.11
 

Sellers (Offers)

Price($) Vol. No.
$1.11 66000 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.